Uses of SunnyRoitin
Sunnyroitin belongs to the category of psychotropic drugs and nerve tonics. The following is information about the uses, dosage and precautions when using Sunnyroitin.
1. Uses of SunnyRoitin
SunnyRoitin medicine has the main ingredient Citicoline, which is made in the form of film-coated tablets and packaged in a box of 3 blisters x 10 tablets. With the main ingredient is Citicoline, the drug is used to treat cerebrovascular disorders, stroke, headache, dizziness, memory impairment, trouble sleeping, forgetfulness, cerebral ischemia, Parkinson's disease and brain injury. In addition, Sunnyroitin is also used in cases of helping to improve thinking, learning and memory in people with Alzheimer's disease.
2, Dosage and how to use SunnyRoitin
Sunnyroitin is usually indicated for use with the usual dose: Take 1 tablet / time x 2-3 times / day with food or as specifically directed by a doctor. Note: The above dosage is for reference only. To have a specific dose, it must depend on the condition and progress of each patient. Appropriate dosage, patients need to consult a doctor or pharmacist.
How to use:
Sunnyroitin is taken into the body through oral route. Treatment of overdose:
Patients who accidentally overdose should be treated symptomatically. Treatment when 1 dose is missed:
If the patient forgets to take a dose, it should be taken as soon as possible. If it is almost time for the next dose to be missed, skip the missed dose and take the next dose as scheduled. Note, the patient should not take double the prescribed dose.
3. Notes when using SunnyRoitin
Sunnyroitin can not be used by people who are hypersensitive to Citicoline or any of its ingredients. Side effects:
The most common side effect during the use of Sunnyroitin is vomiting; Side effects have been noted during the use of Sunnyroitin, but rarely shock if hypotension, chest tightness and shortness of breath occur; Patients may also experience loss of appetite while taking the drug; Other side effects reported were hypersensitivity rash, burning sensation, temporary drop in blood pressure, and general discomfort. When experiencing the symptoms mentioned above or any discomfort while using the drug, the patient should stop taking and notify the doctor for appropriate supportive treatment advice.
Patients with severe or progressive disturbances of consciousness or cerebral hemorrhage, if medication is necessary, should be very cautious. In these cases, it is necessary to combine with antihypertensive drugs, hemostatic drugs and antipyretic drugs; Due to the lack of data on the safety of the drug in long-term use, only the minimum dose should be used and prolonged use should be avoided; For children and young children when it is necessary to use the drug should be cautious; This medicine should not be used in patients with rare hereditary problems of galactose intolerance, lactase deficiency or glucose-galactose malabsorption; Citicoline contained in SunnyRoitin does not currently have adequate and best-controlled studies in pregnant women, so the benefits and risks should be carefully weighed when using this drug for this population; Caution should be exercised when administering the drug to a nursing woman, as there are no adequate studies on whether Citicoline is excreted in breast milk. Drug Interactions:
The plasma concentrations of Citicoline in the brain and liver will be significantly increased because of 4-hydrogen antipyrine; The effect of L-dopa is enhanced by the presence of Citicoline; Do not combine Sunnyroitin with Meclofenoxate, Centrofenoxine. Above is information about uses, dosage and precautions when using Sunnyroitin. To ensure health safety and maximize the effectiveness of treatment, you need to take Sunnyroitin exactly as directed by your doctor, do not increase or decrease the dose or give prescriptions to others to use.
Để đặt lịch khám tại viện, Quý khách vui lòng bấm số HOTLINE hoặc đặt lịch trực tiếp TẠI ĐÂY. Tải và đặt lịch khám tự động trên ứng dụng MyVinmec để quản lý, theo dõi lịch và đặt hẹn mọi lúc mọi nơi ngay trên ứng dụng.